Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Understanding Kawasaki Disease
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Clinical characteristics in Kawasaki disease related to intravenous... | Download Table
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness | PLOS ONE
Kawasaki disease: an update on diagnosis and treatment. | Semantic Scholar
IVIG resistance-related cytokines in Kawasaki disease | Download Table
Kawasaki Dis Canada su Twitter: "Approximately 10% to 20% of patients with Kawasaki disease develop recrudescent or persistent fever at least 36 hours after the end of their IVIG infusion and are
Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin | Semantic Scholar
Kawasaki Disease: An Update on Diagnosis and Treatment - ScienceDirect
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial - The Lancet
Diagnosis and Management of Kawasaki Disease | AAFP
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
Frontiers | Kawasaki Disease
Kawasaki Disease: Complications and Treatment | American Heart Association
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
JCI - Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
Figure 1 | Archives of Disease in Childhood
Refractory Kawasaki disease: diagnostic and management challenges | PHMT
